Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.

{"article_title":"Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.","author":"Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, Mandrekar J","journal_title":"Cephalalgia : an international journal of headache","issn":"1468-2982","isbn":"","publication_date":"2019-05-01","volume":"39","issue":"6","first_page":"687","page_count":"","accession_number":"30806518","doi":"","publisher":"Sage Publications\u00a0","doctype":"Guideline","subjects":"Clinical Trials as Topic standards; Migraine Disorders therapy; Research Design standards; Adult; Female; Humans; Male","interest_area":["Neurology"],"abstract":"The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine. Scientific and clinical developments in headache medicine led to second and third editions in 2000 and 2012, respectively. The current, fourth edition of the Guidelines retains the structure and much content from previous editions. However, it also incorporates evidence from clinical trials published after the third edition as well as feedback from meetings with regulators, pharmaceutical and device manufacturers, and patient associations. Its final form reflects the collective expertise and judgement of the Committee. These updated recommendations and commentary are intended to meet the Society's continuing objective of providing a contemporary, standardized, and evidence-based approach to the conduct and reporting of randomised controlled trials for the acute treatment of migraine attacks.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=30806518","isPdfLink":true,"isSAML":false,"an":"30806518","number_other":"","type_pub":"","issn_electronic":"1468-2982","languages":"English","language":"eng","date_entry":"","date_update":"","titleSource":"Cephalalgia : an international journal of headache [Cephalalgia] 2019 May; Vol. 39 (6), pp. 687-710. Date of Electronic Publication: 2019 Feb 26.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2019-05-01","description":"The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine. Scientific and clinical developments in headache medicine led to second and third editions in 2000 and 2012, respectively. The current, fourth edition of the Guidelines retains the structure and much content from previous editions. However, it also incorporates evidence from clinical trials published after the third edition as well as feedback from meetings with regulators, pharmaceutical and device manufacturers, and patient associations. Its final form reflects the collective expertise and judgement of the Committee. These updated recommendations and commentary are intended to meet the Society's continuing objective of providing a contemporary, standardized, and evidence-based approach to the conduct and reporting of randomised controlled trials for the acute treatment of migraine attacks.","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=30806518&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, Mandrekar J","header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"30806518","RelevancyScore":"861","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"861.13134765625"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=30806518&authtype=shib&custid=ns346513&group=main&profile=eds","physicalDescription":{"Pagination":{"StartPage":"687"}},"additionalInfo":{"Authored_By":"Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, Mandrekar J","Corporate_Authors":"International Headache Society Clinical Trials Standing Committee","Journal_Info":"Publisher: Country of Publication: England NLM ID: 8200710 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2982 (Electronic) Linking ISSN: 03331024 NLM ISO Abbreviation: Cephalalgia Subsets: MEDLINE","Publication_Type":"Guideline; Journal Article","Published_Date":"2019-05-01","Source":"Cephalalgia : an international journal of headache [Cephalalgia] 2019 May; Vol. 39 (6), pp. 687-710. Date of Electronic Publication: 2019 Feb 26.","Languages":"English","Electronic_ISSN":"1468-2982","MeSH_Terms":"Clinical Trials as Topic\/*standards , Migraine Disorders\/*therapy , Research Design\/*standards, Adult ; Female ; Humans ; Male","Subjects":"Adult, Female, Humans, Male, Clinical Trials as Topic standards, Migraine Disorders therapy, Research Design standards","Title_Abbreviations":"Cephalalgia : an international journal of headache","Volume":"39"}}